Moreover, miR-29b-3p reverses cisplatin resistance in non-small cell lung cancer cells by targeting COL1A1 [6], highlighting the critical role of COL1A1 in metastasis and drug resistance. This evidence concerns the gene COL1A1 and non-small cell lung carcinoma.